Ownership history in ORBIMED ADVISORS LLC · 14 quarters on record
This page tracks every 13F SEC filing in which ORBIMED ADVISORS LLC reported a position in MILESTONE PHARMACEUTICALS IN (MIST). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 3,221,828 | +1,221,828 | +61.1% | 0.15% | $6.4M | $2.00 |
| 2024 Q4 | UNCHANGED | 2,000,000 | — | 0% | 0.10% | $4.7M | $2.36 |
| 2024 Q3 | UNCHANGED | 2,000,000 | — | 0% | 0.06% | $3.0M | $1.52 |
| 2024 Q2 | UNCHANGED | 2,000,000 | — | 0% | 0.05% | $2.6M | $1.32 |
| 2024 Q1 | ADDED | 2,000,000 | +182,479 | +10.0% | 0.07% | $3.6M | $1.79 |
| 2022 Q2 | REDUCED | 1,817,521 | -766,300 | -29.7% | 0.20% | $11.2M | $6.15 |
| 2022 Q1 | UNCHANGED | 2,583,821 | — | 0% | 0.27% | $16.6M | $6.42 |
| 2021 Q4 | UNCHANGED | 2,583,821 | — | 0% | 0.22% | $16.9M | $6.55 |
| 2021 Q3 | UNCHANGED | 2,583,821 | — | 0% | 0.16% | $14.8M | $5.71 |
| 2021 Q2 | UNCHANGED | 2,583,821 | — | 0% | 0.14% | $14.2M | $5.50 |
As of 2025 Q4 — sorted by position size